Skip to main content
. 2009 Sep 3;180(11):1114–1121. doi: 10.1164/rccm.200901-0023OC

TABLE 1.

SUBJECT CHARACTERISTICS

P Value
HPS-1 (n = 7) HPS-1 PF (n = 34) NV (n = 85) HPS-1 vs. HPS-1 PF HPS-1 vs. NV HPS-1 PF vs. NV
Age, yr 31.0 ± 4.2 38.6 ± 1.5 38.8 ± 1.4 0.054 0.134 0.947
Sex, M/F 5 / 2 11 / 23 55 / 30
Current smokers 0 0 0
Former smokers 0 3 6
Dyspnea or cough 1 27 0
FEV1, % of predicted 87.5 ± 4.3 85.6 ± 3.4 106.7 ± 1.9 0.803 0.004 <0.001
FVC, % of predicted 82.1 ± 5.1 79.5 ± 3.4 101.5 ± 1.6 0.738 <0.001 <0.001
TLC, % of predicted 84.9 ± 5.6 78.8 ± 3.3 99.5 ± 1.5 0.478 0.006 <0.001
DlCO, % of predicted
85.8 ± 7.7
75.0 ± 3.3
102.8 ± 1.8
0.186
0.009
<0.001

Definition of abbreviations: DlCO = diffusion capacity for carbon monoxide; F = female; HPS-1 = Hermansky-Pudlak syndrome type 1; HPS-1 PF = Hermansky-Pudlak syndrome type 1 with pulmonary fibrosis; M = male; NV = healthy research volunteer; TLC = total lung capacity.